Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability

L Zhang, E Durr, JD Galli, S Cosmi, PJ Cejas, B Luo… - Vaccine, 2018 - Elsevier
Abstract Respiratory Syncytial Virus (RSV) infection is the leading cause of lower respiratory
tract infection in both young children and older adults. Currently, there is no licensed vaccine …
被引用次数：26 相关文章

Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.

L Zhang, E Durr, JD Galli, S Cosmi, PJ Cejas, B Luo… - Vaccine, 2018 - europepmc.org
Respiratory Syncytial Virus (RSV) infection is the leading cause of lower respiratory tract
infection in both young children and older adults. Currently, there is no licensed vaccine …

Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability

L Zhang, AS Espeseth, AJ Bett, E Durr, JD Galli… - Vaccine, 2018 - hero.epa.gov
Abstract Respiratory Syncytial Virus (RSV) infection is the leading cause of lower respiratory
tract infection in both young children and older adults. Currently, there is no licensed vaccine …

Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.

ZL Zhang Lan, E Durr, JD Galli, S Cosmi, PJ Cejas… - 2018 - cabidigitallibrary.org
Abstract Respiratory Syncytial Virus (RSV) infection is the leading cause of lower respiratory
tract infection in both young children and older adults. Currently, there is no licensed vaccine …
[PDF] researchgate.net

[PDF][PDF] Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability

L Zhang, E Durr, JD Galli, S Cosmid, PJ Cejas, B Luo… - Vaccine, 2018 - researchgate.net
abstract Respiratory Syncytial Virus (RSV) infection is the leading cause of lower respiratory
tract infection in both young children and older adults. Currently, there is no licensed vaccine …

Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability

L Zhang, E Durr, JD Galli, S Cosmi, PJ Cejas… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Respiratory Syncytial Virus (RSV) infection is the leading cause of lower respiratory tract
infection in both young children and older adults. Currently, there is no licensed vaccine …

[引用][C] Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability

L Zhang, E Durr, JD Galli, S Cosmi, PJ Cejas, B Luo… - 2018